GASTRIC CANCER (GC)
Clinical trials for GASTRIC CANCER (GC) explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER (GC) trials appear
Sign up with your email to follow new studies for GASTRIC CANCER (GC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat stomach cancer
Disease control Not yet recruitingThis study is testing a new drug combination for people with advanced stomach cancer that has returned or spread after at least two prior treatments. Researchers want to find a safe dose and see if the combination of JPI-547 and irinotecan can shrink tumors. The trial will enroll…
Matched conditions: GASTRIC CANCER (GC)
Phase: PHASE1, PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo tested in fight against advanced cancers
Disease control Not yet recruitingThis study is testing an experimental drug called QLS5132, given by IV in combination with other cancer therapies, for people with advanced solid tumors like lung, stomach, ovarian, and endometrial cancer. The main goals are to find a safe and effective dose and to see how well t…
Matched conditions: GASTRIC CANCER (GC)
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Robot surgeons battle scopes in stomach cancer showdown
Disease control Not yet recruitingThis study aims to find out if robot-assisted surgery helps people with advanced stomach cancer live longer without their cancer returning, compared to traditional laparoscopic (keyhole) surgery. About 335 adults with a specific stage of stomach cancer will be randomly assigned t…
Matched conditions: GASTRIC CANCER (GC)
Phase: PHASE3 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New cell therapy tested for Tough-to-Treat cancers
Disease control Not yet recruitingThis early study is testing a new cell therapy called NK510 for people with advanced stomach or colorectal cancer that has come back or stopped responding to standard treatments. The study will give NK510 through an IV or directly into the abdomen to see if it is safe and if it h…
Matched conditions: GASTRIC CANCER (GC)
Phase: EARLY_PHASE1 • Sponsor: Base Therapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New scan aims to spot hidden tumors more clearly
Diagnosis Not yet recruitingThis study is testing a new type of PET scan designed to improve the detection and staging of colorectal, gastric, and pancreatic cancers. It uses a special imaging agent that targets a protein called GPA33, which is often found on these cancer cells. The goal is to see if this n…
Matched conditions: GASTRIC CANCER (GC)
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
Could a simple stomach fluid test spot cancer sooner?
Diagnosis Not yet recruitingThis study is testing a new method to help diagnose stomach cancer and related diseases. Researchers will collect stomach fluid from 100 patients during their routine endoscopy exams. They will analyze tiny particles in the fluid to see if they can accurately identify signs of ca…
Matched conditions: GASTRIC CANCER (GC)
Sponsor: Beijing Friendship Hospital • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
AI tool aims to personalize stomach cancer care
Knowledge-focused Not yet recruitingThis study aims to develop an artificial intelligence (AI) system to predict how well a patient's stomach cancer will respond to standard drug treatment before surgery. Researchers will collect data from 2,000 patients receiving standard chemo-immunotherapy to train the AI using …
Matched conditions: GASTRIC CANCER (GC)
Sponsor: Qun Zhao • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC